While these results provide encouragement for further investigation of DYRK1A inhibitors for diabetes therapy, concerns about their ultimate practical utility include: 1) When added to human islets, harmine caused a significant increase in proliferation of non-β-cells, including α-cells, δ-cells and ductal cells [5]. This evidence concerns the gene DYRK1A and diabetes mellitus.